Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.
Central dopaminergic and noradrenergic systems play essential roles in controlling several forebrain functions. Consequently, perturbations of these neurotransmissions may contribute to the pathophysiology of neuropsychiatric disorders. For many years, there was a focus on the serotonin (5-HT) system because of the efficacy of selective serotonin reuptake inhibitors (SSRIs), the most prescribed antidepressants in the treatment of major depressive disorder (MDD). Given the interconnectivity within the monoaminergic network, any action on one system may reverberate in the other systems. Analysis of this network and its dysfunctions suggests that drugs with selective or multiple modes of action on dopamine (DA) and norepinephrine (NE) may have robust therapeutic effects. This review focuses on NE-DA interactions as demonstrated in electrophysiological and neurochemical studies, as well as on the mechanisms of action of agents with either selective or dual actions on DA and NE. Understanding the mode of action of drugs targeting these catecholaminergic neurotransmitters can improve their utilization in monotherapy and in combination with other compounds particularly the SSRIs. The elucidation of such relationships can help design new treatment strategies for MDD, especially treatment-resistant depression.
El Mansari
Mostafa
M
University of Ottawa Institute of Mental Health Research, Ontario, Canada. mostafa.elmansari@rohcg.on.ca <mostafa.elmansari@rohcg.on.ca>
Guiard
Bruno P
BP
Chernoloz
Olga
O
Ghanbari
Ramez
R
Katz
Noam
N
Blier
Pierre
P
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002490:Central Nervous System / Q000378:metabolism* / Q000473:pathology; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism*
D000928:Antidepressive Agents; D004298:Dopamine; D009638:Norepinephrine
Arch Gen Psychiatry. 1965 Dec;13(6):483-94
5320621
Neurochem Int. 1992 Mar;20 Suppl:231S-235S
1365432
J Clin Psychiatry. 2006;67 Suppl 4:22-6
16683859
Depress Anxiety. 2000;11(2):58-65
10812530
Neuropharmacology. 2008 Dec;55(7):1191-8
18708076
Int Clin Psychopharmacol. 1997 Jul;12 Suppl 3:S7-14
9347387
Psychopharmacology (Berl). 2002 Aug;163(1):102-5
12185406
Brain Res. 1975 Jul 11;92(2):291-306
1174954
J Clin Psychiatry. 2010 Feb;71(2):163-74
20122366
J Clin Psychiatry. 2005 Oct;66(10):1289-97
16259543
Eur J Pharmacol. 1991 Jul 23;200(1):65-72
1685123
Neuropharmacology. 2006 May;50(6):755-60
16427661
Eur J Neurosci. 2000 Mar;12(3):1079-95
10762339
Biol Psychiatry. 2007 Mar 1;61(5):671-8
16934772
J Neurochem. 1990 Sep;55(3):1067-70
2117046
Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73
8935801
Eur J Pharmacol. 1993 Mar 16;233(1):79-84
8097162
J Psychiatr Res. 2009 Jan;43(3):205-14
18586273
Psychopharmacology (Berl). 2009 Oct;206(2):335-44
19641901
Pharmacopsychiatry. 2001 Jul;34(4):137-41
11518474
Int J Neuropsychopharmacol. 2008 Aug;11(5):625-39
18205979
Life Sci. 1984 Mar 19;34(12):1161-70
6708722
J Pharmacol Exp Ther. 1987 May;241(2):642-9
3033221
J Neurosci. 2002 Jan 15;22(2):389-95
11784783
J Neurochem. 1998 Jul;71(1):274-80
9648875
Annu Rev Neurosci. 2009;32:267-87
19555290
Am J Psychiatry. 2005 Jul;162(7):1351-60
15994719
Psychopharmacology (Berl). 2001 Oct;158(1):1-6
11685378
J Neurosci Res. 2008 May 15;86(7):1647-58
18189323
Biol Psychiatry. 2006 Nov 15;60(10):1111-20
16806100
Neuropsychopharmacology. 2003 Feb;28(2):413-20
12589396
Prog Brain Res. 1990;85:325-35; discussion 335-6
2094903
Neuroscience. 1998 Jun;84(4):1085-96
9578397
Brain Res. 1984 Feb 27;294(1):161-5
6697233
J Comp Neurol. 1994 Jun 1;344(1):121-36
7914895
Am J Psychiatry. 2010 Mar;167(3):281-8
20008946
J Pharmacol Exp Ther. 1995 Oct;275(1):412-21
7562579
Curr Neuropharmacol. 2006 Apr;4(2):115-25
18615131
Eur J Pharmacol. 1977 Aug 15;44(4):375-85
330174
Psychopharmacology (Berl). 2001 Apr;155(1):52-7
11374336
CNS Drugs. 2009;23 Suppl 1:33-41
19621976
J Pharmacol Exp Ther. 1994 Dec;271(3):1216-22
7996429
Neuropsychopharmacology. 2005 Apr;30(4):775-85
15688090
Neuropsychopharmacology. 2008 Sep;33(10):2303-12
18059438
J Pharmacol Exp Ther. 2007 Jan;320(1):376-85
17005915
Nat Rev Neurosci. 2009 Jun;10(6):410-22
19455173
Neuropsychopharmacology. 2001 Dec;25(6):845-57
11750178
J Affect Disord. 2005 Dec;89(1-3):115-23
16213028
N Engl J Med. 2006 Mar 23;354(12):1243-52
16554526
Depress Anxiety. 2006;23(3):178-81
16528701
Synapse. 1990;6(1):106-12
1697988
Am J Psychiatry. 1965 Nov;122(5):509-22
5319766
Neuropharmacology. 1986 Sep;25(9):1003-8
3774122
Arch Gen Psychiatry. 2007 Mar;64(3):327-37
17339521
J Biol Chem. 1994 Mar 11;269(10):7124-30
8125921
J Clin Psychiatry. 1984 Apr;45(4 Pt 2):56-9
6370976
J Comp Neurol. 2000 May 1;420(2):211-32
10753308
Synapse. 2000 Feb;35(2):111-9
10611636
Cereb Cortex. 2007 Sep;17 Suppl 1:i6-15
17434919
J Clin Psychiatry. 1984 Apr;45(4 Pt 2):78-84
6370982
Int J Neuropsychopharmacol. 2005 Sep;8(3):329-39
15737250
J Affect Disord. 1998 Dec;51(3):255-66
10333981
J Comp Neurol. 1979 Sep 1;187(1):117-43
489776
Int J Neuropsychopharmacol. 2011 Mar;14(2):211-23
20149268
J Neural Transm. 1987;70(3-4):183-91
2445911
Curr Drug Targets. 2009 Nov;10(11):1069-84
19702555
Neuropsychopharmacology. 1994 Oct;11(2):133-41
7840865
J Neurochem. 2001 May;77(3):762-75
11331405
Eur J Pharmacol. 1978 Nov 1;52(1):27-36
214312
J Pharmacol Exp Ther. 2001 May;297(2):540-6
11303041
Neuropsychopharmacology. 1992 Aug;7(1):7-14
1381923
Psychopharmacology (Berl). 2005 Aug;181(1):126-33
15719213
Naunyn Schmiedebergs Arch Pharmacol. 1977 Mar;297(1):1-7
193046
Am J Psychiatry. 1999 May;156(5):798
10327923
Brain Res Bull. 1982 Jul-Dec;9(1-6):321-53
6816390
Brain Res. 1991 Nov 15;564(2):203-19
1839781
Neuropsychopharmacology. 2009 Feb;34(3):651-61
18688211
J Neurosci. 2009 Mar 18;29(11):3613-26
19295165
Neuroscience. 1987 Jan;20(1):117-55
2882443
Arch Gen Psychiatry. 1996 Feb;53(2):117-28
8629887
Synapse. 2004 Jun 15;52(4):233-44
15103690
J Clin Psychopharmacol. 2003 Jun;23(3):233-9
12826985
J Neurochem. 1994 Jul;63(1):195-200
8207428
Biol Psychiatry. 2006 Feb 1;59(3):203-10
16165100
J Clin Psychiatry. 2006 Jan;67(1):148-59
16426101
Biol Psychiatry. 2004 Jun 1;55(11):1103-9
15158430
Eur J Neurosci. 2001 Jun;13(11):2077-87
11422448
J Clin Psychopharmacol. 2000 Apr;20(2):274-5
10770475
Neuropharmacology. 2002 Feb;42(2):181-90
11804614
J Clin Psychiatry. 2005;66 Suppl 8:30-40
16336034
J Clin Psychiatry. 1995 Sep;56(9):395-401
7665537
Brain Res. 1977 May 20;127(1):1-21
67877
CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207
17227286
Psychopharmacology (Berl). 1994 Jun;115(1-2):285-8
7862908
J Pharmacol Exp Ther. 1994 Mar;268(3):1297-303
8138943
Mol Pharmacol. 2008 Nov;74(5):1463-75
18703671
Adv Biochem Psychopharmacol. 1977;16:433-8
883551
Neuropharmacology. 1983 Nov;22(11):1257-67
6320035
Psychopharmacology (Berl). 1997 Dec;134(3):309-17
9438681
J Biol Chem. 1994 Jun 10;269(23):15985-8
8206893
Trends Pharmacol Sci. 1994 Jul;15(7):220-6
7940983
Neuron. 1995 Mar;14(3):477-85
7695894
Cell. 2007 Apr 20;129(2):397-410
17448997
J Neurosci. 1996 Mar 1;16(5):1922-35
8774459
J Psychopharmacol. 2010 Aug;24(8):1223-35
19939862
J Clin Psychiatry. 2008 Feb;69(2):246-58
18363453
Eur J Pharmacol. 2000 Apr 21;395(1):31-6
10781670
Neuropharmacology. 1980 Apr;19(4):355-63
6104308
Annu Rev Neurosci. 2009;32:57-74
19400725
Sleep. 2003 Nov 1;26(7):801-6
14655911
Psychopharmacology (Berl). 2011 Sep;217(1):61-73
21445565
Neuropharmacology. 1989 Dec;28(12):1383-8
2533329
Eur J Pharmacol. 2004 Nov 3;504(1-2):61-4
15507222
Biol Psychiatry. 1992 Jul 1;32(1):1-17
1391289
Depress Anxiety. 2004;20(3):131-8
15549689
CNS Spectr. 2009 Apr;14(4):197-206
19407731
Crit Rev Neurobiol. 2004;16(1-2):121-8
15581407
Ann Intern Med. 2007 Nov 6;147(9):593-602
17975181
J Neurophysiol. 2006 Dec;96(6):3006-15
17005616
Psychopharmacology (Berl). 2007 Sep;194(1):63-72
17530476
Eur J Pharmacol. 1989 Jun 8;165(1):11-8
2569981
Biol Psychiatry. 2003 Oct 15;54(8):800-5
14550679
J Neurosci. 1998 Feb 15;18(4):1613-21
9454866
J Pharmacol Exp Ther. 1984 Nov;231(2):275-80
6491980
J Neural Transm. 1979;44(1-2):77-86
220380
J Pharmacol Exp Ther. 2002 Sep;302(3):983-91
12183655
J Pharmacol Exp Ther. 1986 Jun;237(3):987-94
2423685
Behav Brain Funct. 2005 Apr 22;1(1):2
15916700
J Comp Neurol. 1985 Jan 8;231(2):190-208
2981906
Bipolar Disord. 2002 Oct;4(5):307-14
12479663
J Comp Neurol. 2005 Sep 26;490(3):270-94
16082674
Brain Res. 1998 Jan 1;779(1-2):58-74
9473588
J Appl Physiol (1985). 2003 Aug;95(2):652-6
12692144
Science. 1979 Aug 31;205(4409):929-32
112679
Neuropsychopharmacology. 2002 Aug;27(2):237-47
12093597
Ann Clin Psychiatry. 2000 Sep;12(3):137-40
10984002
Neuropsychopharmacology. 2003 Jun;28(6):1140-9
12700697
Eur J Pharmacol. 2001 Apr 27;418(3):177-86
11343687
Brain Res Brain Res Rev. 1997 Apr;23(3):145-95
9164669
Nat Neurosci. 2007 Mar;10(3):376-84
17277774
J Clin Psychopharmacol. 2006 Dec;26(6):600-9
17110817